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Abstract
ASAP1 is a multi-domain adaptor protein that regulates cytoskeletal dynamics, receptor
recycling and intracellular vesicle trafficking. Its expression is associated with poor progno-
sis for a variety of cancers, and promotes cell migration, invasion and metastasis. Little is
known about its physiological role. In this study, we used mice with a gene-trap inactivated
ASAP1 locus to study the functional role of ASAP1 in vivo, and found defects in tissues
derived from mesenchymal progenitor cells. Loss of ASAP1 led to growth retardation and
delayed ossification typified by enlarged hypertrophic zones in growth plates and disorga-
nized chondro-osseous junctions. Furthermore, loss of ASAP1 led to delayed adipocyte
development and reduced fat depot formation. Consistently, deletion of ASAP1 resulted in
accelerated chondrogenic differentiation of mesenchymal cells in vitro, but suppressed
osteo- and adipogenic differentiation. Mechanistically, we found that FAK/Src and PI3K/
AKT signaling is compromised in Asap1GT/GT MEFs, leading to impaired adipogenic differ-
entiation. Dysregulated FAK/Src and PI3K/AKT signaling is also associated with attenuated
osteogenic differentiation. Together these observations suggest that ASAP1 plays a deci-
sive role during the differentiation of mesenchymal progenitor cells.
Author summary
Mesenchymal progenitor cells are capable of differentiating into a number of lineages
including osteoblasts, chondrocytes and adipocytes, and have therefore attracted interest
for their potential application in regenerative medicine. Furthermore, defects in mesen-
chymal progenitor cell differentiation are considered to contribute to various diseases
including metabolic syndrome, obesity and osteoporosis. In this study, we analyzed
mice deficient in the multi-adaptor protein ASAP1, which has been implicated in tumor
progression and metastasis. These mice display growth retardation, and a delayed
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development of bone and fat tissue. Consistently, mesenchymal progenitor cells deficient
in ASAP1 exhibited enhanced differentiation into chondrocytes, but impaired differentia-
tion into adipocytes and osteoblasts. Together these observations suggest that ASAP1
plays a decisive role during the differentiation of mesenchymal stem cells, which may be
relevant for a number of diseases such as cancer.
Introduction
Mesenchymal stem cells (MSCs) are multipotent progenitor cells capable of differentiating
into a number of lineages including osteoblasts, chondrocytes and adipocytes. Due to their
multipotency, MSCs have attracted interest for their potential application in regenerative med-
icine. In addition, impairment of mesenchymal differentiation is considered to contribute to
many diseases, including metabolic syndrome, obesity and osteoporosis [1–3].
Mesenchymal differentiation is regulated by key transcription factors that are specific for
each lineage. Osteogenic differentiation is driven by the transcription factor Runx2, and leads
to the formation of new bone in the process of osteogenesis. Together with the osteoblast-spe-
cific transcription factor osterix, Runx2 induces the expression of matrix proteins such as
osteocalcin, osteopontin, bone sialoprotein and collagen I, which leads to the maturation of
osteoblasts and subsequent mineralization of the bone matrix [4, 5].
Chondrogenesis involves the differentiation of mesenchymal progenitor cells into chondro-
cytes and the formation of cartilage, and is initiated by the condensation of mesenchymal cells.
The transcription factor Sox9 is required for chondrogenic determination, and drives the
expression of early chondrocyte-specific genes such as collagen 2a and aggrecan [6, 7]. Later,
Sox9 is down-regulated and the transcription factor Runx2 promotes hypertrophy, which is
marked by expression of Indian hedgehog (Ihh), collagen X and MMP13 [8].
The formation of adipocytes from mesenchymal progenitor cells is driven by the transcrip-
tion factor PPARγ, the master regulator of adipogenesis [9–11]. Together with the CCAAT-
enhancer-binding protein α (C/EBPα), PPARγ activates the transcription of genes expressed
in mature adipocytes such as adiponectin, perilipin and Glut4 [9].
In the embryo, most bones are formed by endochondral ossification, in which chondrocytes
generate a cartilage model that guides future bone formation, and form the growth plate, a
highly organized zone of chondrocyte proliferation, maturation and hypertrophy [8, 12]. Mes-
enchymal cells in the perichondrium surrounding the cartilage differentiate into osteoprogeni-
tor cells [13]. Together with osteoclasts, blood vessels and hematopoietic cells, they invade into
the hypertrophic cartilage to form the primary ossification center, which leads to replacement
of the cartilage with bone marrow and mineralized bone.
Mesenchymal differentiation is modulated by a complex network of intracellular and extra-
cellular signals. Intracellularly, focal adhesion kinase (FAK) and the non-receptor kinase Src
are pivotal signaling molecules that coordinate cytoskeletal changes during lineage differentia-
tion, and which are functionally implicated in adipogenic, osteogenic and chondrogenic differ-
entiation [14–19]. Thus, inhibition of FAK signaling by siRNA or chemical inhibitors prevents
adipogenic differentiation [14]. Similarly, inhibition of Src-family tyrosine kinases prevents fat
accumulation [15]. Furthermore, FAK promotes osteogenic differentiation while Src inhibits
osteogenesis [16, 17].
FAK activation is regulated by growth factor receptors or integrins at the plasma mem-
brane. Integrin-ECM interactions promote dimerization of FAK and its auto-phosphorylation
at Y397 [20]. This facilitates binding of Src to FAK, and allows the phosphorylation of the FAK
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kinase domain by Src. Active FAK in turn phosphorylates Src at Y416 [21]. FAK phosphory-
lated at Y397 also interacts with the regulatory subunit of phosphoinositide 3-kinase (PI3K),
leading to activation of the serine/threonine kinase AKT [22]. In addition, activation of the
FAK/Src complex stimulates other signaling cascades, including MEK/ERK, p38 and GTPases
of the Rho family, and promotes migration, proliferation and differentiation [21].
ASAP1, also called AMAP1 or DDEF1, is a multi-domain adaptor protein involved in cyto-
skeletal re-arrangement, cell motility and metastasis. ASAP1 is an Arf GTP activating protein
with activity for ADP-ribosylation factors Arf1 and Arf5, and is a downstream effector of Arf6
[23–25]. ASAP1 contains a BAR domain, as well as a proline-rich domain and a SH3 domain
that allow ASAP1 to interact with a variety of intracellular regulatory proteins including FAK,
Src, cortactin, and IKKβ [23, 25–27]. Overexpression of ASAP1 promotes focal adhesion for-
mation and enhanced migration, whereas loss of ASAP1 inhibits podosome and invadopodia
formation, and reduces spreading on fibronectin [26, 28–30]. Furthermore, ASAP1 regulates
integrin β1 recycling, and thereby promotes cancer cell invasion [31]. Previously, we have
shown that ASAP1 promotes the migration and metastasis of pancreatic tumor cells in vivo
and correlates with poor survival of colorectal patients [32]. Furthermore, ASAP1 expression
is upregulated in a variety of other tumors including breast, prostate carcinomas and uveal
melanomas [25, 33, 34].
Here, we investigated the physiological role of ASAP1 by analyzing mice with a gene-trap-
inactivated ASAP1 locus, and found that ASAP1 is strongly expressed during embryonic
development. Loss of ASAP1 in vivo resulted in partial perinatal lethality, delayed ossification,
and a decreased bodyweight associated with reduced amounts of fat tissue. Using primary
MEF cultures in vitro, we found that loss of ASAP1 suppressed osteo- and adipogenic differen-
tiation, but promoted chondrogenic differentiation. Mechanistically, ASAP-deficient MEFs
failed to activate FAK/Src and AKT signaling appropriately upon induction of adipogenesis or
osteogenesis. These data identify ASAP1 as a pivotal intracellular regulator of mesenchymal
progenitor cell differentiation that acts through the regulation of FAK/Src-AKT signaling.
Results
Generation and analysis of ASAP1 gene-trap mice
To determine the physiological role of ASAP1 in vivo, we used mice bearing the gene-trap tar-
geting vector pGT0Lxf integrated into the ASAP1 locus. This vector contains a splice-acceptor
sequence upstream of a β-geo reporter gene and a polyA tail. Genomic integration results in
disruption of the coding sequence of the targeted gene and the concomitant expression of the
β-geo marker, allowing cells in which the targeted gene is expressed to be detected using X-gal
staining [35, 36].
Whole genome sequencing was used to confirm specific targeting of the ASAP1 locus,
which revealed integration of the gene-trap vector into the ASAP1 gene on chromosome 15
between nucleotides 64,308,443 and 64,316,218, and a concurrent deletion of the correspond-
ing part of the ASAP1 gene including exon 3 (nt 64,312,349–64,312,475) (Fig 1A). The
sequence information was used to develop a genomic PCR amplification strategy for genotyp-
ing (S1 Fig). No other pGT0Lxf vector integration sites were found in the genome sequence,
verifying unique disruption of the ASAP1 locus in the mice.
Heterozygous Asap1GT mice were intercrossed to generate E10.5 and E11.5 embryos that
were genotyped and subsequently analyzed by RT-PCR, Western blot and X-Gal staining. The
insertion of the gene-trap vector resulted in the ablation of ASAP1 transcripts and protein
expression (Fig 1B and 1C), while expression of lacZ could be detected in Asap1+/GT and
Asap1GT/GT mice using X-Gal staining (Fig 1D). Using primer pairs covering different parts of
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the ASAP1 mRNA, we verified that the 31 exons of the ASAP1 locus 3’ to the insertion site of
the gene-trap vector were not expressed (S1 Fig).
Asap1GT/GT mice are susceptible to perinatal lethality, and display growth
retardation
Intercrosses of heterozygous Asap1+/GT mice were used to produce Asap1+/+, Asap1+/GT and
Asap1GT/GT mice. Analysis of the Mendelian ratio of 3-week-old litters showed that Asap1GT/GT
Fig 1. Characterization of ASAP1 gene-trap mice. (A) Schematic diagram showing ASAP1 gene locus (upper part) and integration of the pGT0Lxf
gene-trap vector (lower part). SA: splice acceptor; β-geo: β-geo reporter cassette; pA: polyadenylation signal; E: exon; nt: nucleotide. (B and C)
ASAP1 expression is lost in Asap1GT/GT embryos. mRNA and protein expression of ASAP1 was determined in E11.5 Asap1+/+, Asap1+/GT and
Asap1GT/GT embryos using semi-quantitative RT-PCR and Western blot. Two embryos per genotype were analyzed for protein expression. HPRT
and vinculin served as loading controls. (D) X-Gal staining of E10.5 Asap1+/+, Asap1+/GT and Asap1GT/GT embryos. (E) Table showing differences in
Mendelian ratios at birth. Heterozygous mice were intercrossed and genotype of progeny was analyzed at embryonic day E11.5, E13.5, E15.5 and
E18.5 and at day of birth, P0. Numbers indicate percentage of genotypes among embryos analyzed. (F) Analysis of embryo size at E15.5 (Asap1+/+ n
= 8, Asap1+/GT n = 15 and Asap1GT/GT n = 8) and P0 (Asap1+/+ n = 35, Asap1+/GT n = 62 and Asap1GT/GT n = 19) measured from crown to rump. (G)
Analysis of weight at E18.5 (Asap1+/+ n = 20, Asap1+/GT n = 51 and Asap1GT/GT n = 27) and P0 (Asap1+/+ n = 35, Asap1+/GT n = 62 and Asap1GT/GT n
= 19). (H) Analysis of respiratory rate at P0. Three independent measurements per embryo were taken (Asap1+/+ n = 35, Asap1+/GT n = 62 and
Asap1GT/GT n = 19). For F-H, graphs show mean ± SD. Significance was calculated using the Student’s t-test. �, p< 0.05, � p< 0.005, � p< 0.001.
https://doi.org/10.1371/journal.pgen.1008216.g001
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mice were significantly underrepresented in the progeny (S1 Fig). Analysis of embryos from
E11.5 up to birth revealed no differences in the Mendelian ratio between Asap1+/+, Asap1+/GT
and Asap1GT/GT embryos during gestation. At P0, however, the number of Asap1GT/GT animals
was substantially reduced, suggesting that Asap1GT/GT neonates died during or directly after
birth (Fig 1E).
From E15.5 onwards, Asap1GT/GT embryos exhibited a reduced size compared to Asap1+/+
embryos (Fig 1F). At E18.5 and P0, Asap1GT/GT embryos also had a significantly lower body
weight compared to Asap1+/+ embryos (Fig 1G). Furthermore, Asap1GT/GT neonates displayed
a reduced respiratory rate during the first day after birth (Fig 1H). The respiratory rate recov-
ered in Asap1GT/GT neonates that survived the first day after birth, and the surviving pups
reached adulthood.
ASAP1 is expressed in cartilage tissue and the heart
To characterize the expression pattern of ASAP1 in embryonic and adult tissues, the β-geo
reporter integrated into the ASAP1 locus of Asap1GT/GT mice was used. Homozygous
Asap1GT/GT embryos of different embryonic stages were stained with X-Gal. In E9.5 embryos,
the β-geo reporter was widely expressed, including in the heart and branchial arches (Fig 2A).
At E10.5 and E11.5, ASAP1 was expressed in the heart, the branchial arches, the limb buds and
in the somites (Fig 2B and 2C). In E12.5 embryos, ASAP1 was strongly expressed in the Y-
shaped mesenchymal condensations of the developing limbs and in the developing pharynx
(Fig 2D and 2D1). From E13.5 to P0, β-geo reporter expression was found in the somites (Fig
2E and 2E1), the developing limbs (Fig 2F and 2G), the nasal capsule, pharynx and cochleae
(Fig 2E and 2I), the heart (Fig 2H), and the trachea and bronchi (Fig 2J and 2K).
Fig 2. ASAP1 is strongly expressed in the developing skeleton, heart and trachea. X-Gal staining of Asap1GT embryos at E9.5 (A), E10.5
(B), E11.5 (C), E12.5 (D), E13.5 (E). Enlarged images of the developing fore limb of an E12.5 embryo (D1) and the spine of an E13.5
embyro (E1). (F and G) Staining of prepared forelimbs of E13.5 and E18.5 embryos. (H) β-geo reporter expression in the E13.5 heart. (I
and J) β-geo reporter expression in the skull and lung at E18.5. (K) β-geo reporter expression in the trachea at P0. Scale bars: 0.5 mm.
Abbreviations: ba, branchial arch; ea, ear; fl, fore limb; h, heart; hl, hind limb; hu, humerus; la, left atrium; lv, left ventricle; nc, nasal cavity;
mc, meckel’s cartilage; ph, pharynx; ra, right atrium; rv, right ventricle; so, somites; tr, trachea.
https://doi.org/10.1371/journal.pgen.1008216.g002
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Expression of ASAP1 in the lung bronchi and heart was also confirmed in adult animals,
together with expression in the liver, brain, spleen, skin and testis (S2 Fig). Despite the wide-
spread expression of ASAP1 in many tissues, ASAP1-deficient mice that survived the first day
after birth were reproductively viable, had equivalent longevity to their wild-type littermates
and did not exhibit any predisposition to develop autochthonous tumors.
ASAP1 has been implicated in angiogenesis and endothelial cell migration [37]. We also
found that ASAP1 is expressed in lymphatic vessels (S3 Fig). However, ASAP1-deficient mice
did not exhibit obvious defects in the vasculature. Nevertheless, to investigate a possible role
for ASAP1 during angiogenesis and/or lymphangiogenesis in more detail, we examined angio-
genesis in neonatal retinas from Asap1+/+ and Asap1GT/GT mice, and performed ex vivo tho-
racic duct ring assays to investigate possible differences in lymphangiogenesis. Using these
assays, no differences in angiogenesis or lymphangiogenesis between the different genotypes
were observed (S3 Fig).
Loss of ASAP1 delays ossification during embryogenesis
The strong expression of ASAP1 in the cartilage tissue during mouse development and the
growth retardation observed at birth prompted us to investigate whether loss of ASAP1 results
in defective cartilage or bone formation. Chondroskeletal staining was performed using E15.5
and E18.5 wild-type and Asap1GT/GT embryos. At E15.5, we found that Asap1GT/GT embryos
were smaller in size, had shorter skulls and that the length and width of the femur was reduced
compared to wild-type animals (Fig 3A–3D, 3G, 3H and 3K). Furthermore, ossification of the
lumbar vertebrae, the frontal bone of the cranial vault, the premaxilla and the mandible of
Asap1GT/GT embryos was delayed (Fig 3E–3H and 3L). At E18.5, reduced femur width was
again observed in Asap1GT/GT embryos, although the femur length was not significantly differ-
ent between Asap1+/+ and Asap1GT/GT embryos (Fig 3M). Furthermore, the ossification of the
proximal and distal phalanges was delayed in Asap1GT/GT compared to wild-type embryos (Fig
3I, 3J and 3N). Together, these data suggest that loss of ASAP1 delays bone development.
To investigate the role of ASAP1 in bone development in more detail, the consequence of
loss of ASAP1 on growth plate development in E15.5 embryos was analyzed. Alcian Blue/ von
Kossa double staining revealed an increase in the hypertrophic zone in Asap1GT/GT animals
(Fig 4A–4D and 4U). Consistently, the expression area of the hypertrophic marker collagen X
and the osteogenic markers osteocalcin and osteopontin was expanded, and the chondro-osse-
ous junction (the transition between chondrocytes and mineralized bone) appeared disorga-
nized, indicative of premature hypertrophy (Fig 4E–4P). Interestingly, ASAP1 was expressed
in the perichondrium, in osteoblasts and in terminally differentiated chondrocytes, suggesting
a role in late chondrogenesis and the genesis of osteoblasts (Fig 4Q–4T).
Loss of ASAP1 results in reduced adipogenesis in vivo
Asap1GT/GT neonates showed reduced body weight compared to wild-type animals (Fig 1F). As
ASAP1 overexpression promotes the adipogenic differentiation of immortalized 3T3 fibroblasts
through its proline-rich and SH3 domains [38], we investigated whether the decreased body
weight of ASAP1 deficient mice is associated with reduced adipocyte development. The develop-
ment of white adipose tissue occurs largely after birth, but sub-dermal lipid-filled adipocytes can
already be detected around birth [9]. We analyzed the subcutaneous region of the scapula for peri-
lipin A-positive cells, and found that Asap1GT/GT neonates exhibit significantly fewer subcutane-
ous adipocytes compared to their Asap1+/+ littermates (Fig 5A and 5B). Furthermore, the body
weight of male and female mice was monitored for several months, which revealed that male
Asap1GT/GT mice gained less weight compared to WT littermates, whereas there was no difference
ASAP1 regulates MSC differentiation
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in females (Fig 5C and 5D). At the age of 18 months, the bodyweight of male Asap1GT/GT mice
was significantly lower compared to control mice, and there was a similar trend in female
Asap1GT/GT mice (Fig 5E). All mice had smaller perigonadal and retroperitoneal fat depots com-
pared to their WT littermates, while other organs such as liver, kidney or heart were not affected
(Fig 5F and 5G). In addition to a decrease in the weight of fat depots, the size of adipocytes in peri-
gonadal WAT was also reduced in Asap1GT/GT mice (Fig 5H–5J). These observations suggest that
Asap1GT/GT mice have a defect in the generation of adipocytes and the accumulation of lipids, sup-
porting the notion that ASAP1 promotes adipogenesis in vivo.
Loss of ASAP1 interferes with osteo- and adipogenic terminal
differentiation
The results above suggest that ASAP1 is involved in the generation of chondrocytes, osteo-
blasts and adipocytes, differentiated cell lineages that are derived from mesenchymal
Fig 3. Loss of ASAP1 delays ossification. (A-H) Chondroskeletal staining of E15.5 Asap1+/+ (A, C, E, G) and Asap1GT/GT embryos (B, D,
F, H), demonstrating reduced whole body size (A, B) and reduced size and ossification of hind limbs (C, D), lumbar vertebra (E, F) and
skull (G, H) in Asap1GT/GT embryos. (I, J) Chondroskeletal staining of E18.5 embryos, demonstrating reduced ossification of proximal and
distal phalangeal bones in Asap1GT/GT embryos. (K, L) Quantification of femur length, width and number of ossified lumbar vertebrae in
E15.5 embryos (Asap1+/+ n = 7, Asap1GT/GT n = 6). (M, N) Quantification of femur length and width (Asap1+/+ n = 5, Asap1GT/GT n = 5) and
the number of proximal and distal ossification centers in E18.5 embryos (Asap1+/+ n = 8, Asap1GT/GT n = 8, left and right). For K and M, the
box-whisker plots show the mean values and the 25th and 75th percentiles ± SD. For L and N, graphs show the mean ± SD. Significance was
calculated using the Student’s t-test�, p< 0.05, �� p< 0.005, ��� p< 0.001. p, proximal; d, distal.
https://doi.org/10.1371/journal.pgen.1008216.g003
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progenitor cells. Therefore, we investigated the role of ASAP1 during mesenchymal differenti-
ation in vitro.
To investigate the role of ASAP1 during chondrogenic differentiation, limb bud mass cul-
tures from Asap1+/+ and Asap1GT/GT E11.5 embryos were stained with Alcian Blue to detect
proteoglycan synthesis. Asap1GT/GT cultures showed a trend towards increased Alcian Blue
staining compared to wild-type controls (Fig 6A). Furthermore, transcription of chondrogenic
Fig 4. Loss of ASAP1 results in expansion of the hypertrophic zone. (A-D) E15.5 Asap1+/+ and Asap1GT/GT growth plates of the humerus
stained for Alcian Blue / von Kossa in blue and black, respectively. The length of the hypertrophic zone (hz) is demarcated by a black bar. (E-T)
Immunostaining of E15.5 Asap1+/+ and Asap1GT/GT humeral growth plates. Staining of the hypertrophic marker collagen X (E-H) and the
osteogenic markers osteocalcin (I-L) and osteopontin (M-P) was detected by Nova Red and counterstained with hematoxilin. ASAP1
immunostaining indicates specific expression of ASAP1 in the perichondrium, in late hypertrophic chondrocytes and in the primary
ossification center (Q-T). The scale bars shown at the bottom of the panels apply to all pictures above the given scale bar. (U) Quantification of
the distal hypertrophic zones of the humerus of Asap1+/+ and Asap1GT/GT animals (Asap1+/+ n = 5, Asap1GT/GT n = 5). Graphs show the
mean ± SD. Significance was calculated using the Student’s t-test. ��, p<0.005.
https://doi.org/10.1371/journal.pgen.1008216.g004
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markers such as aggrecan and Indian hedgehog was significantly increased in Asap1GT/GT
compared to wild-type limb bud mass cultures (Fig 6B), suggesting that loss of ASAP1 pro-
motes chondrogenesis, consistent with the finding that loss of ASAP1 results in expansion of
the hypertrophic zone.
Next, we differentiated Asap1+/+ and Asap1GT/GT primary MEFs into the osteogenic lineage
to investigate the regulation of osteogenesis by ASAP1. After 14 days of differentiation-induc-
ing treatment, Asap1+/+ and Asap1GT/GT MEFs were assessed for osteogenic differentiation. In
Fig 5. Loss of ASAP1 results in decreased numbers of neonatal subcutaneous adipocytes and reduced body weight. (A) Transverse sections at the
level of the scapulae of neonatal WT and Asap1GT/GT embryos were stained for perilipin A (green fluorescence) and DAPI (blue), which demonstrated a
reduced number of perilipin A-positive subcutaneous adipocytes in Asap1GT/GT neonates (P0). (B) Quantification of the number of subcutaneous
adipocytes. The number of perilipin A-positive cells per picture of three adjacent scapulae sections was counted and averaged. The box-whisker plots
show the mean values and the 25th and 75th percentiles for Asap1+/+ (n = 5) and Asap1GT/GT embryos (n = 6) ± min to max. (C) Body weight (BW) of
male WT and Asap1GT/GT mice at the age of 10 to 40 weeks. Data represents mean ± SEM (Asap1+/+, n = 10 and Asap1GT/GT, n = 6). (D) Body weight
(BW) of female WT and Asap1GT/GT mice at the age of 10 to 40 weeks. Data represents mean ± SD (Asap1+/+, n = 6 and Asap1GT/GT, n = 6). (E) Body
weight of male and female WT and Asap1GT/GT mice at the age of 18 months. The box-whisker plots show the mean values and the 25th and 75th
percentiles for Asap1+/+ (male n = 11, female n = 9) and Asap1GT/GT (male n = 8, female n = 8) ± min to max. (F and G) Weight of perigonadal WAT
(pgWAT), retroperitoneal WAT (rpWAT), liver, kidney and heart of WT and Asap1GT/GT mice at the age of 18 months. (H) Representative pictures of
male (upper panels) and female (lower panels) pgWAT of aged WT and Asap1GT/GT mice (age 18 months). (I) Distribution of adipocyte size in pgWAT
from WT and Asap1GT/GT male mice (Asap1+/+ n = 6, Asap1GT/GT n = 5). (J) Distribution of adipocyte size in pgWAT from WT and Asap1GT/GT female
mice (Asap1+/+ n = 4, Asap1GT/GT n = 4). Significance was calculated using the Student’s t-test.�, p< 0.05, �� p< 0.005.
https://doi.org/10.1371/journal.pgen.1008216.g005
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Asap1+/+ cells, von Kossa-positive nodules and Alizarin Red staining could be readily detected
(Fig 6C). In contrast, no von Kossa or Alizarin Red staining was observed in Asap1GT/GT cells.
Impaired osteogenic differentiation in Asap1GT/GT cells was further confirmed by analyzing
transcription of the osteogenic transcription factor osterix and the matrix proteins osteocalcin
and bone sialoprotein. Asap1+/+ cells showed a strong increase in expression of these factors,
whereas no expression was detected in Asap1GT/GT cells (Fig 6D). Interestingly, the induction
of Runx2 was not affected by the loss of ASAP1, suggesting that part of the osteogenic differen-
tiation program is induced in the absence of ASAP1, but cannot be completed.
Fig 6. Loss of ASAP1 promotes chondrogenesis but prevents mineralization in vitro. (A) Limb bud mass cultures
of Asap1+/+ and Asap1GT/GT embryos were stained with Alcian Blue after seven days of differentiation. Two
representative pictures per genotype are shown (left panel). Alcian Blue was extracted and the OD measured at 630
nm. The data represent the mean ± SD (Asap1+/+ n = 18, Asap1GT/GT n = 18). Scale bars: 1 mm. Significance was
calculated using the Student’s t-test (right panel). (B) qPCR analysis of limb bud mass cultures after seven days of
differentiation. Relative mRNA expression was analyzed for aggrecan and Indian hedgehog, and normalized to RibP0
expression. Data represent the mean ± SD (Asap1+/+ n = 8, Asap1GT/GT n = 8). Significance was calculated using the
Student’s t-test.� p< 0.05. (C) Asap1+/+and Asap1GT/GT MEFs were differentiated into the osteogenic lineage and
stained for mineral deposition by von Kossa and Alizarin Red. Representative pictures of differentiated Asap1+/+ and
Asap1GT/GT MEFs are shown (left panel). Quantification of von Kossa positive nodules (right panel). The graph
represents the mean ± SD of three biological replicates for three independent MEF cell lines per genotype. Scale bars: 2
mm. Significance was calculated using the Student’s t-test. ��� p< 0.0005 (D) Late osteogenic markers are not induced
in ASAP1-deficient cells. qPCR analysis of differentiating MEFs at day 3, day 8 and day 14 and untreated control cells.
Relative mRNA expression was analyzed for Runx2, ALP, osteopontin, osterix, osteocalcin and bone sialoprotein, and
normalized to expression of RibP0. Data represent the mean ± SEM (Asap1+/+, n = 4 and Asap1GT/GT, n = 5).
https://doi.org/10.1371/journal.pgen.1008216.g006
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Finally, we investigated whether loss of ASAP1 also impacts on adipogenesis. Primary
MEFs were differentiated into the adipogenic lineage by addition of insulin, IBMX, dexameth-
asone and troglitazone. After 7 days of differentiation, Asap1+/+ and Asap1GT/GT cells were
stained for Oil Red O, and analyzed for adipogenic gene expression. Asap1+/+ cells strongly dif-
ferentiated into adipocytes, as demonstrated by Oil Red O staining (Fig 7A and 7B), began to
express the adipogenic marker C/EBPα and PPARγ after 3 days, and showed high expression
of PPARγ, adiponectin and Glut4 after 5 and 7 days (Fig 7C). By contrast, differentiated
Asap1GT/GT MEFs stained poorly with Oil Red O. Although C/EBPβ was regulated similarly to
Asap1+/+ cells, the Asap1GT/GT cells did not exhibit subsequent high induction of PPARγ and
Fig 7. Loss of ASAP1 abrogates adipogenic differentiation in vitro. (A) Asap1+/+and Asap1GT/GT MEFs were
induced to differentiate into the adipogenic lineage, and stained for Oil Red O. Representative images of uninduced
controls and differentiated cells after 7 days are shown (upper panel). Scale bars: 200 μm. (B) Quantification of Oil Red
O staining (lower panel). Oil Red O was extracted and the OD measured at 540 nm. The graph represents the
mean ± SD of one representative experiment out of three performed, each of which was performed with three
biological replicates. Significance was calculated using the Student’s t-test. ��� p< 0.0005. (C) Adipogenic markers are
not induced in differentiated ASAP1-deficient cells. qPCR analysis of differentiating MEFs at day 0, 3 and day 7.
Relative mRNA expression was analyzed for C/EBPβ, C/EBPα, PPARγ, adiponectin, Glut4 and ASAP1, and
normalized to expression of RibP0. Data represent the mean ± SD (Asap1+/+, n = 3 and Asap1GT/GT, n = 3).
Significance was calculated using the Student’s t-test. �, p< 0.05, �� p< 0.005.
https://doi.org/10.1371/journal.pgen.1008216.g007
ASAP1 regulates MSC differentiation
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008216 June 27, 2019 11 / 25
C/EBPα, or later expression of the adipogenic markers adiponectin and Glut4 (Fig 7C). Inter-
estingly, ASAP1 expression was strongly suppressed in Asap1+/+ cells during early adipogenic
differentiation, but returned to basal levels after 7 days. These results demonstrate that ASAP1
is required for terminal differentiation of mesenchymal progenitor cells into adipocytes.
ASAP1 promotes adipogenic differentiation through regulating FAK/Src
and Akt signaling
To understand at the mechanistic level how loss of ASAP1 suppresses adipogenic differentia-
tion in vivo and in vitro, we next investigated the impact of ASAP1 deficiency on key regula-
tory signaling proteins. As ASAP1 interacts with FAK and Src via its proline-rich and SH3
domains [23, 26], and both molecules are functionally involved in adipogenic differentiation
[14, 15], we hypothesized that dysregulated FAK/Src signaling may contribute to the
phenotype observed in Asap1GT/GT MEFs. Consistent with this notion, we found that phos-
phorylation of FAK was reduced in ASAP1-deficient MEFs after induction of adipogenic dif-
ferentiation compared to wild-type controls (Fig 8A). Furthermore, phosphorylation of Src
was also reduced (Fig 8A). These results indicate that FAK/ Src signaling is hampered in
Asap1GT/GT MEFs, consistent with incomplete adipogenic differentiation.
Next, we used loss and gain of function approaches to demonstrate a mechanistic role for FAK
in ASAP1-dependent adipogenic differentiation. Treatment of MEFs with the FAK inhibitor PF-
573228 completely abrogated adipogenesis in WT MEFs (Fig 8B). Ectopic expression of a consti-
tutive active form of FAK (CD2-FAK) in Asap1GT/GT MEFs rescued the induction of adipogenic
differentiation almost as effectively as re-introduction of ASAP1 into the cells (Fig 8C–8E).
Together, these data suggest that FAK is involved functionally in ASAP1-dependent adipogenic
differentiation. Interestingly, mutation of the proline-rich domain P1 of ASAP1 (ASAP1-R811A),
which decreases binding of ASAP1 to Src SH3 domain proteins including Src, did not impair the
ability of ASAP1 to restore adipogenic differentiation in Asap1GT/GT MEFs (Fig 8C–8E).
ERK, p38 and AKT are signal transduction components down-stream of FAK that have
been implicated in regulating adipogenesis [14, 39, 40]. We therefore hypothesized that activa-
tion of these components may be impaired in Asap1GT/GT MEFs after induction of adipogenic
differentiation. Consistent with this notion, induction of adipogenic differentiation in WT
MEFs strongly induced activation of AKT and p38 through phosphorylation of key residues
(Fig 8F). By contrast, activation of AKT was completely abrogated, and activation of p38 was
significantly impaired upon induction of adipogenic differentiation in Asap1GT/GT MEFs,
while phosphorylation of ERK was not significantly affected (Fig 8F). As AKT signaling is
essential for insulin-induced adipogenic differentiation [41], these results suggest that the
ability of ASAP1 to promote adipogenic differentiation may also require AKT activation.
We therefore investigated whether constitutively active FAK activates AKT signaling in
Asap1GT/GT MEFs to rescue the adipogenic phenotype. Indeed, phosphorylation of AKT T308
was induced when Asap1GT/GT MEFs expressing constitutively active FAK were differentiated
into the adipogenic lineage (Fig 8G).
Given the role of ASAP1 in regulating cytoskeletal dynamics and adhesion, we analyzed
focal adhesions in WT and Asap1GT/GT MEFs before and during induction of adipogenesis.
No obvious differences were observed in the distribution, size or number of focal adhesions in
WT and Asap1GT/GT MEFs (S4 Fig). We also did not observe differences in cell adhesion on a
variety of substrates when WT and Asap1GT/GT MEFs were compared (S4 Fig). Together, these
results suggest that the FAK/Src-PI3K/AKT signaling pathway is defective in Asap1GT/GT
MEFs, which leads to impaired adipogenic differentiation, but does not impact on focal adhe-
sion formation or cell adhesion.
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Fig 8. FAK/ Src and Akt signaling is impaired in Asap1GT/GT MEFs, which inhibits adipogenic differentiation. (A) FAK and Src
phosphorylation is impaired when Asap1GT/GT MEFs are induced to differentiate into the adipogenic lineage. Protein lysates of
undifferentiated controls and WT and Asap1GT/GT MEFs at day 3 and day 7 after induction of differentiation were analyzed by Western
blotting. Blots were probed with the antibodies indicated on the left. (B) Inhibition of FAK activity by PF-573228 prevents adipogenesis in
MEFs. WT and Asap1GT/GT MEFs were induced to differentiate into the adipogenic lineage with or without 10 μM PF-573228. Scale bars:
500 μm. (C) Asap1GT/GT MEFs were infected with control, CD2-FAK, ASAP1c or ASAP1-R811A retroviruses. Protein lysates of infected
MEFs were analyzed by Western blotting. Blots were probed with the antibodies indicated on the left. (D) Enforced FAK activity in
Asap1GT/GT MEFs rescues the induction of adipogenesis. Control Asap1GT/GT MEFs and Asap1GT/GT MEFs ectopically expressing
CD2-FAK, ASAP1c or ASAP1-R811A were differentiated into the adipogenic lineage, and after seven days of differentiation they were
stained with Oil Red O. Scale bars: 200 μm. (E) Control Asap1GT/GT MEFs and Asap1GT/GT MEFs ectopically expressing CD2-FAK,
ASAP1c or ASAP1-R811A were differentiated into the adipogenic lineage. At adipogenic day 7, relative mRNA expression was analyzed
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Loss of ASAP1 deregulates Src and AKT signaling during osteogenesis
FAK/Src and AKT also play pivotal roles during osteogenesis [16, 17, 42]. We therefore investi-
gated FAK/Src and AKT signaling upon induction of osteogenic differentiation in Asap1GT/GT
MEFs. FAK protein levels were slightly increased in Asap1GT/GT MEFs compared to Asap1+/+
MEFs under osteogenesis-inducing conditions, but the degree of FAK phosphorylation
appeared similar in both genotypes (Fig 8H). However, compared to Asap1+/+ MEFs, phos-
phorylation of Src was strongly increased in Asap1GT/GT MEFs upon osteogenic stimuli (Fig
8H). As Src activation prevents osteogenesis [17], this may explain why Asap1GT/GT MEFs
exhibit an impaired ability to differentiate into the osteogenic lineage. Furthermore, AKT
phosphorylation was strongly induced in WT MEFs upon induction of osteogenic differentia-
tion whereas it was completely attenuated in Asap1GT/GT MEFs. These results suggest that dys-
regulation of FAK/Src-PI3K/AKT signaling in Asap1GT/GT MEFs may also contribute to
diminished osteogenic differentiation.
Discussion
In this study, we found that ASAP1 plays an essential role in mesenchymal differentiation in
vivo and in vitro. ASAP1 deficiency impaired embryonic growth, delayed ossification, attenu-
ated adipocyte development, and reduced body fat formation. Consistently, mesenchymal pro-
genitor cells deficient in ASAP1 were seriously hampered in their ability to differentiate into
the osteogenic and adipogenic lineages. Impaired adipogenic differentiation in Asap1GT/GT
MEFs was rescued by FAK activation, and defective adipogenic and osteogenic differentiation
were both associated with dysregulated Src and AKT signaling. These data demonstrate new
functional roles for ASAP1 in the differentiation of mesenchymal progenitor cells.
Although ASAP1 deficiency did not impair adult survival or aging, disruption of ASAP1
resulted in around 50% perinatal lethality. Surviving Asap1GT/GT neonates were growth-
retarded and exhibited breathing difficulties at birth. It is therefore conceivable that problems
with impaired lung development and inflation at birth, or transient developmental deficits in
other components of the respiratory system may contribute to the partial lethal phenotype of
Asap1GT/GT mice.
Several observations implicate ASAP1 in bone development. First, ASAP1 was strongly
expressed in the mesenchymal condensations of the developing limbs, and at E15.5, expression
was observed in the perichondrium, mature hypertrophic chondrocytes and in cells of the pri-
mary spongiosa. Second, delayed ossification of the limbs, vertebrae and of the skull was
observed in ASAP1-deficient animals, indicating that ASAP1 plays a general role in endochon-
dral and intramembranous ossification. Third, loss of ASAP1 resulted in an increase in the
for PPARγ and adiponectin, with normalization relative to the expression of RibP0. Data represent the mean ± SD. Significance was
calculated using the Student’s t-test. �, p< 0.05, �� p< 0.01. (F) AKT signaling is abrogated when Asap1GT/GT MEFs are induced to
differentiate. Protein lysates of undifferentiated controls and WT and Asap1GT/GT MEFs at day 3 and day 7 after induction of
differentiation were analyzed by Western blotting. Blots were probed with the antibodies indicated on the left. (G) Constitutively active
FAK induces AKT phosphorylation when Asap1GT/GT MEFs are induced to differentiate. Protein lysates of undifferentiated controls and
Asap1GT/GT MEFs expressing empty control vector or CD2-FAK at day 3 after induction of adipogenic differentiation were analyzed by
Western blotting. Blots were probed with the antibodies indicated on the left. (H) Src and AKT signaling is dysregulated when Asap1GT/GT
MEFs are induced to differentiate into the osteogenic lineage. Protein lysates of undifferentiated controls and WT and Asap1GT/GT MEFs
at day 3 and day 7 after induction of osteogenic differentiation were analyzed by Western blotting. Blots were probed with the antibodies
indicated on the left. (I) Schematic model of ASAP1-dependent signaling during the differentiation of mesenchymal progenitor cells,
proposed on the basis of the results in this paper and other observations in the literature. FAK activation by integrins leads to auto-
phosphorylation of T397, a process regulated by ASAP1 through regulation of integrin recycling. T397 phosphorylation enables recruitment
and activation of Src, leading to full activation of FAK, and binding of the PI3K regulatory subunit to FAK. ASAP1 regulates FAK/Src and
AKT phosphorylation. Activation of the FAK/Src complex results in phosphorylation of down-stream signaling pathways including ERK,
p38 and AKT, which in turn determine the differentiation fate of mesenchymal progenitor cells.
https://doi.org/10.1371/journal.pgen.1008216.g008
ASAP1 regulates MSC differentiation
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008216 June 27, 2019 14 / 25
hypertrophic zone in developing femurs, indicating that ASAP1 may prevent premature
hypertrophy. As ASAP1 is not expressed in pre-hypertrophic or hypertrophic chondrocytes, it
is conceivable that loss of ASAP1 can influence chondrogenesis by deregulating the tight inter-
action between the growth plate and perichondrium. In addition, ASAP1 deficiency promoted
chondrogenic differentiation and prevented osteogenic differentiation of mesenchymal pro-
genitors in vitro. Taken together, our results strongly suggest that ASAP1 is necessary for oste-
ogenic differentiation of mesenchymal progenitor cells, and that loss of ASAP1 expression
therefore leads to defects in bone development.
Our data also implicate ASAP1 in regulating adipogenic differentiation. The reduced num-
ber of lipid-filled subcutaneous adipocytes in Asap1GT/GT neonates and the smaller fat depots
and reduced size of adipocytes in older Asap1GT/GT mice compared to their wild-type litter-
mates is consistent with the impaired ability of Asap1GT/GT MEFs to undergo adipogenic dif-
ferentiation that we observed in vitro. Mechanistically, we found that adipogenic lineage
commitment is not prevented by the loss of ASAP1, as C/EBPβ is not differentially regulated
upon adipogenic stimulation. However, expression of the key adipogenic regulators PPARγ
and C/EBPα, and late adipogenic genes such as adiponectin and Glut4 were not efficiently
induced, suggesting that loss of ASAP1 impedes terminal differentiation.
During the first 40 weeks of life, we observed a difference in male and female weight devel-
opment. Male Asap1GT/GT mice were leaner and did not gain as much weight as their WT lit-
termates, while there was no significant difference between female mice. However, when WT
and Asap1GT/GT mice were aged to 18 months, we also observed reduced fat depot weight and
adipocyte size in female Asap1GT/GT mice. Several observations suggest that estrogens may
underlie the differences in weight development in female and male Asap1GT/GT mice compared
to wild-type littermates. Male mice are generally more susceptible to obesity and related dis-
eases, and estrogens are thought to protect against the development of obesity and metabolic
syndromes [43, 44]. This is reflected by the increased prevalence of insulin resistance and obe-
sity in post-menopausal women. Consistently, ovariectomized mice mimic male mice in their
susceptibility to weight gain [44]. Increased estrogen levels may therefore explain why the
effect of ASAP1 deficiency on bodyweight and adipogenesis is partially concealed in female
Asap1GT/GT mice.
At the molecular level, ASAP1 physically interacts with FAK and Src [23, 26], two proteins
that regulate adipogenic, osteogenic and chondrogenic differentiation [14–19]. We found that
loss of ASAP1 impedes activating phosphorylation of FAK and c-Src during adipogenic differ-
entiation of MEFs. A constitutively active form of FAK at least partially rescued the defects in
adipogenesis seen in Asap1GT/GT MEFs, indicating that loss of ASAP1 impairs adipogenesis
through defective activation of FAK/Src signaling. ASAP1 has previously been thought to be
downstream of FAK and Src signaling [23, 26], but our results indicate that ASAP1 can also
affect the activity of both of these proteins. Activation of integrins promotes auto-phosphoryla-
tion of FAK, and subsequently the formation of an activated FAK/Src complex [20]. As
ASAP1 regulates the recycling of β1 integrins [31], we speculate that loss of ASAP1 may
impede activation of FAK/ Src signaling through the regulation of integrin recycling. Further-
more, ASAP1 binds to FAK via its SH3 domain, but binds to Src via its proline-rich domain
[23, 26]. We found that mutation of the proline-rich domain of ASAP1 (ASAP1-R811A) did
not impair the ability of ASAP1 to rescue adipogenic differentiation in ASAP1-deficient
MEFs, which would suggest that direct binding of ASAP1 to Src is not required for ASAP1-
mediated adipogenic differentiation.
Analysis of signaling pathways downstream of FAK also revealed that activation of the
PI3K-activated serine/threonine kinase AKT was severely hampered in ASAP1-deficient
MEFs. PI3K/AKT signaling is a critical component in insulin-induced adipogenesis [41].
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Furthermore, deletion of AKT in mice results in severe growth retardation, delayed bone
development and impaired adipogenesis [39], reminiscent of the Asap1GT/GT phenotype we
report here. The impaired adipogenic potential of AKT-deficient cells results from an inability
to induce PPARγ expression [39]. Thus, the defects in adipogenesis seen in Asap1GT/GT mice
are consistent with impaired activation of down-stream targets of FAK and AKT in Asap1GT/
GT MEFs.
FAK/Src and AKT signaling are also implicated in osteogenesis [16, 17, 42]. Although no
apparent differences in FAK phosphorylation were observed between in Asap1GT/GT and
Asap1+/+ MEFs undergoing osteogenic differentiation, Asap1GT/GT MEFs exhibited markedly
increased Src phosphorylation, and attenuated AKT activation. In contrast to the situation in
adipogenesis, Src activation inhibits osteogenesis [17, 45]. Therefore, the increased phosphory-
lation of Src Y416 seen in Asap1GT/GT MEFs could account for the delayed osteogenesis in
Asap1GT/GT mice. Furthermore, inhibition of AKT prevents osteogenesis, consistent with the
attenuated osteogenic differentiation and impaired activation of AKT that we observed in
Asap1GT/GT MEFs [42]. Again, these observations are consistent with the notion that dysregu-
lated FAK/Src and AKT signaling in ASAP1-deficient MEFs contributes to defective osteo-
genic differentiation.
In contrast to its role in osteogenic and adipogenic differentiation, loss of ASAP1 fostered
chondrogenesis. This effect may also be due to dysregulated FAK/Src and AKT signaling. Loss
of FAK activity increases chondrogenic differentiation, and inhibition of FAK prevents dedif-
ferentiation of chondrocytes, indicating that FAK negatively regulates chondrogenic differen-
tiation [18, 19]. PI3K/AKT signaling is also activated in proliferating chondrocytes and down-
regulated as they terminally differentiate [46]. Therefore, impaired AKT signaling may also
contribute to increased chondrogenesis upon loss of ASAP1. Taken together, our results sug-
gest that ASAP1 represents a regulatory hub that coordinates FAK/Src and PI3K/AKT signal-
ing, and thereby regulates the differentiation of mesenchymal progenitor cells (Fig 8I).
ASAP1 has been functionally implicated in the regulation of cell motility in vitro due to its
ability to coordinate dynamic remodeling of the cytoskeleton, in particular the formation of
structures that are required for cell migration such as focal adhesions, podosomes and invado-
podia [47]. Key ASAP1 interaction partners that mediate these cytoskeletal changes include
FAK and Src [26, 28–30]. AKT, whose activity is deregulated by loss of ASAP1, is also an
important regulator of cell motility that acts through cytoskeletal reorganization [48]. Re-
arrangement of the actin cytoskeleton plays a pivotal role during mesenchymal progenitor cell
differentiation [49–51], and our data show that FAK, Src and AKT activity is deregulated by
loss of ASAP1 during adipogenesis and osteogenesis. Although we did not observe any differ-
ences in focal adhesion formation when WT and ASAP1-deficient MEFs were compared,
there are clear common links at the molecular level between the roles of ASAP1 in cell migra-
tion on the one hand, and in regulating the differentiation of mesenchymal progenitor cells on
the other.
To our knowledge, this is the first report of an involvement of ASAP1 in regulating AKT
signaling. Mechanistically, ASAP1 could affect PI3K/AKT signaling by regulating FAK/Src sig-
naling, as the regulatory subunit of PI3K directly interacts with phosphorylated FAK [22].
However, it is also possible that ASAP1 regulates AKT activity by other means. We note, for
example, that Arf1 regulates AKT activation upon growth receptor activation, and that ASAP1
regulates Arf1 through its ArfGAP activity [30, 52]. Thus, ASAP1 deficiency may also impact
on AKT signaling through impaired Arf1 activity.
Regulation of AKT activity by ASAP1 may be relevant for cancer progression. ASAP1 is fre-
quently amplified and overexpressed in a variety of cancers, which correlates with metastasis
and poor survival [25, 32–34]. As the PI3K/AKT pathway is one of the most commonly
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dysregulated pathways in cancer [53], future work will investigate whether ASAP1 overexpres-
sion can activate AKT signaling in cancer cells, and whether this impacts on the treatment of
tumor patients with amplified or overexpressed ASAP1.
Materials and methods
Ethics statement
All mice were maintained under conventional housing conditions in accordance with German
government and institute guidelines and regulations. Permission was granted by the Regier-
ungspra¨sidium Karlsruhe for the experiments in this study (Permit Number: 35–9185.81/G-
299/16). Mice were sacrificed by cervical dislocation. Embryos were sacrificed by decapitation
or immersion in liquid nitrogen.
Mice
A chimeric mouse (B6; 129P2-Asap1GT(RRS873)Byg/Mmucd) with a gene-trap targeted ASAP1
allele (hereafter referred to as Asap1GT) was obtained from the Mutant Mouse Resource
Research Center repository (University of California, Davis, CA, USA) [36] and back-crossed
with FVB wild-type mice for at least eight generations to obtain a congenic line on the FBV
background. Heterozygous progeny were intercrossed to obtain Asap1+/+, Asap1+/GT and
Asap1GT/GT embryos and neonates for analysis. For embryo analysis, heterozygous Asap1+/GT
mice were time-mated, and pregnant mice were sacrificed to obtain embryos at the indicated
time points. Clearly dead or resorbed embryos were excluded from analysis.
Whole genome sequencing
A DNA sequencing library from an Asap1GTmouse was produced from 1 μg of genomic DNA
following the recommendations of the TruSeq DNA protocol (Illumina, San Diego, CA, USA).
Briefly, integrity of the extracted DNA (~100ng) was confirmed by electrophoresis on a 1%
agarose gel. DNA was sheared to 200 bp fragments by sonication with a Covaris S220 instru-
ment using the following settings: peak incidence power 175 W, duty factor 10%, cycle per
burst 200, time 430 seconds. Fragmented genomic DNA was processed for end-repair, A-tail-
ing, ligation of adapters and enrichment by 11 cycles of PCR following Illumina recommenda-
tions. The quality and quantity of the sequencing library was determined on a Bioanalyzer
2100 (DNA1000 chips, Agilent, Santa Clara, CA, USA). Paired-end sequencing (2x50bp) of the
library adjusted to 8pM was performed on one lane with TruSeq PE Cluster KIT v3 –cBot–HS
and TruSeq SBS KIT v3 –HS kits on the Hiseq1000 (Illumina) platform. Cluster detection and
base calling were performed using RTAv1.13 and the quality of reads was assessed with
CASAVA v1.8.1 software (Illumina). The sequencing resulted in 120 million 50 nt-long reads
(6Gbases), with a mean Phred quality score > 37 for both reads.
To identify the integration site of the GeneTrap vector, we aligned all sequencing reads
against the mouse genome (GRCm38/mm10 assembly) with the Burrows-Wheeler aligner
BWA 0.6.1 in paired- end mode [54]. Resulting files (BAM format) were merged, filtered out
for duplicated pairs and sorted by chromosome coordinates with picard-tools-1.43 (http://
picard.sourceforge.net). Visual inspection of the aligned sequences on the mouse genome with
IGV2.0 [55] led to the detection of a region of 7.7 kb without mapped reads centered on the
ASAP1 exon 3 at the coordinates chr15:64,308,444–64,316,208. Further inspection of read
pairs at the border of this region confirmed the presence of chimeric fragments with identity
to the targeting vector pGToLxf. This information was used to design a PCR-based genotyping
strategy.
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Genotyping the Asap1GT allele
Genotyping was performed by a three primer PCR-based protocol using genomic DNA pre-
pared either from tail clips of pups or yolk sacks from embryos. The following primers were
used: Asap1_for 5’-GCATCGCCTGTCATCCTACA-3’, Asap1_rev 5’-CTACTTACTCCTA-
CATCTGAGATCC-3’ and Gene-trap_for 5’-TCGATGTAACCCACTCGTGC-3’ (see S1 Fig).
Whole mount lac Z staining
Whole mount lacZ staining was performed on embryos of different stages. Dissected embryos
were fixed in 4% PFA for 1-2h depending on the developmental age. Fixed embryos were pre-
incubated in rinse buffer (PBS, 0.1% Tween 20) and stained overnight in staining solution con-
taining 5 mM K3Fe(Cn)6, 5 mM K4Fe(Cn)6 and 1 mg/ml X-Gal. After staining, embryos were
washed, post-fixed and cleared in a serial dilution of 20%, 50% and 75% glycerol in 1% KOH.
For analysis, stained embryos were submerged in 100% glycerol and pictures were taken with
a Leica stereomicroscope (Leica, Wetzlar, Germany).
Chondroskeletal staining
Alcian Blue and Alizarin Red staining of skeletons was performed as previously published
[56]. In brief, E18.5 embryos were de-skinned and eviscerated, while E15.5 embryos were evis-
cerated only, then fixed in 100% EtOH. After 48h in acetone, embryos were stained overnight
at 37˚C in 0.005% Alizarin Red (Sigma, St. Louis, MO, USA), 0.015% Alcian Blue (Sigma), and
5% acetic acid in 70% EtOH. Skeletons were cleared in 1% KOH overnight and transferred
stepwise into increasing concentrations of glycerol (20%, 50%, 75% in 1% KOH). Pictures of
skeletons were taken in 100% glycerol with a Leica stereomicroscope.
Histological analysis
Limbs and the scapular region from embryos and neonates were fixed in formalin, dehydrated
and embedded in paraffin. For immunohistochemical analysis, limbs were decalcified in 15%
EDTA for 72h, then 4 μm-thick sections were obtained. Dewaxed and re-hydrated sections of
non-decalcified limbs were stained in 1% Alcian Blue in 3% acetic acid or von Kossa stain and
counterstained with nuclear fast red. For immunohistochemical analysis, antigen retrieval was
performed using proteinase K for osteocalcin, or citrate buffer (DAKO, Santa Clara, CA, USA)
for all other antibodies. The following antibodies were used: ASAP1 (#NBP2-48909, Novus
biological, Littleton, CO, USA), collagen X (#orb 10444, Biorbyt, San Francisco, CA, USA),
osteocalcin (#7060–1815,Biorad, Hercules, CA, USA) osteopontin (#AF808, R&D, Minneapo-
lis, MN, USA) and perilipin A (#P1998, Sigma). Staining was detected by ABC Kit and visual-
ized with Nova Red (Vectorlabs, Burlingame, CA, USA). For immunofluorescence staining, a
secondary antibody conjugated with Alexa 488 (Invitrogen, Carlsbad, CA, USA) was used fol-
lowed by counterstaining with diamidinophenylindole (DAPI). Images were taken using a
Zeiss Axio Imager (Zeiss, Oberkochen, Germany).
Culture and differentiation of mouse embryonic fibroblasts
Primary MEFs were isolated from E13.5 embryos. The head and organs were removed, then
embryos were minced and incubated in trypsin overnight at 4˚C. The next day, the trypsin
was removed, and the tissue was incubated for 15–20 min at 37˚C. Then, cells were resus-
pended in DMEM (Life Technologies, Carlsbad, CA, USA) supplemented with 10% FCS
(Sigma), 1% Pen/Strep (Life Technologies) and 2 mM L-glutamine (Life Technologies), and
plated. Yolk sacs were used for genotyping. Differentiation experiments were performed with
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MEFs of passage 2–4. For osteogenic differentiation, cells were plated at 2 x 104 cells/cm2 and
treated with 50 μg/ml ascorbic acid (#49752, Sigma), 10 Mm β-glycerophosphate (G9422,
Sigma) and 200 ng/ml BMP2 (#355-BM, R&D). Cells were incubated with this differentiation
cocktail over a period of 14 days with medium changes every 3–4 days. RNA was harvested at
the indicated time points. After 14 days of differentiation, cells were fixed in formalin prior to
staining with von Kossa stain or Alizarin Red. For adipogenic differentiation, cells were plated
at high density (3.5 x 104 cells/ cm2) and grown to post-confluency. After seven days, cells
were induced to differentiate with 5 μg/ml insulin, 0.5 μM IBMX, 1 μM dexamethasone and
10 μM troglitazone (all from Sigma) for three days. Then, cells were incubated with mainte-
nance medium containing 5 μg/ml insulin and 10 μM troglitazone for two days. Medium was
changed to normal growth medium for two additional days. RNA was harvested at the indi-
cated time points, or cells were stained with Oil Red O.
Limb bud mass culture
Limb buds were dissected from E11.5 embryos and digested in 0.1% collagenase IV and
0.025% trypsin for 30 min at 37˚C. Single cells were counted and plated in 20 μl drops at
107cells/ml. After 1h, DMEM F12 medium containing 10% FCS, 50 μg/ml ascorbic acid and 10
mM β-glycerophosphate was added, and cells were cultured for 7 days.
Histological staining of cells
Mineral deposition was evaluated by von Kossa and Alizarin Red staining. For von Kossa
staining, formalin-fixed cells were incubated with 5% AgNO3 for 15 minutes followed by 5
minutes of 1% pyrogallol. After fixation with 5% sodium thiosulfate solution, cells were rinsed
with H2O and images were taken. For Alizarin Red staining, formalin-fixed cells were incu-
bated with 2% Alizarin Red for 1 h (#A5533, Sigma), rinsed with H2O and images were cap-
tured. Proteoglycan synthesis was evaluated using Alcian Blue staining. Cells were fixed in 4%
PFA and stained with 0.1% Alcian Blue in 0.1 N HCl overnight. Cells were washed and stored
in 70% EtOH for image capturing. Alcian Blue was extracted using 6 M guanine-HCl and the
OD was measured at 630 nm. Lipid droplet formation was assessed by Oil Red O staining. For-
malin-fixed cells were rinsed in 60% isopropanol for 2 minutes. Subsequently, cells were incu-
bated in Oil Red O staining solution (Sigma) prepared following the instruction of the
manufacturer for 30 minutes, then rinsed with H2O before images were taken. Oil Red O was
extracted by addition of isopropanol containing 4% NP40 and the OD was measured at 540
nm.
Retroviral infection
pQCXIP-CD2-FAK was generated by cloning CD2-FAK from pLV-neo-CD2-FAK (Addgene)
into the pQXCIP vector. PlatE cells were transfected with 9 μg empty pQCXIP vector, or with
vectors containing CD-2FAK, ASAP1c or ASAP1-R811A [32] using FuGENE (Promega).
Supernatant containing retroviruses were transferred to Asap1GT/GT MEFs of passage 1 or 2.
After selection with 0.5 μg/ml puromycin, cells were plated for adipogenic differentiation as
described above.
RNA isolation and qPCR
RNA was isolated using Trizol (Invitrogen) according to the manufacturer’s protocol. Subse-
quently, 1.5–2 μg of RNA was digested with 5 U DNaseI (Thermo Fisher Scientific, Waltham,
MA, USA) for 30 min at 37˚C. The reaction was stopped by addition of EDTA and heat
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inactivation, then the RNA was transcribed into cDNA using reverse transcriptase (Thermo
Fisher Scientific) according to manufacturer’s protocol. Gene expression was analyzed using
SYBR-Green mix (Applied Biosciences, Waltham, MA, USA) to perform real-time qPCR
using the One Step Plus Realtime PCR System (Applied Biosciences) under the following PCR
conditions: 15 sec 95˚C, 1 min 60˚C, 1 min 72˚C. The ribosomal protein PO (RibPO) was
used as a control to normalize the data. The primer pairs used to amplify the indicated cDNAs
are listed in S1 Table.
Western blot analysis
Mouse tissues and cells for protein lysates were lysed in RIPA buffer, homogenized by a Tissue
LyserII (Qiagen, Venlo, Netherlands) and quantified using the BCA Protein Assay Kit
(Thermo Fisher Scientific). Lysates were subjected to 8% or 10% SDS-PAGE and transferred
to a PVDF membrane. Protein expression was analyzed using rabbit anti-ASAP1 (ab12423,
1:2500, Abcam, Cambridge, UK), rabbit anti-FAK (06–543, 1:1000, Merck Milipore, Darm-
stadt, Germany), rabbit anti-phospho FAK Y397 (44-624G, 1:1000, Thermofisher), rabbit anti-
Src (ab47405, 1:1000, abcam), rabbit anti-phospho Src Y416 (#6943, 1:1000, Cell Signaling),
rabbit anti-phospho AKT T308 (#9275, 1:1000, Cell Signaling), rabbit anti-AKT (sc-8312, 1,
1:200, Santa Cruz), rabbit anti-ERK (sc-93, 1:200, Santa Cruz), mouse anti-phospho ERK
(#9106, 1:1000, Cell Signaling), rabbit anti-p38 (sc535, 1:200, Santa Cruz), rabbit anti-phospho
p38 (#4511, 1:1000, Cell Signaling). Probing the membranes with mouse anti-vinculin anti-
bodies (V4139, 1:5000, Sigma) served as a loading control.
Statistics
Differences between two groups were analyzed by a two-tailed unpaired Student’s t-test using
Graphpad Prism. P values < 0.05 were considered statistically significant and indicated as fol-
low: � p< 0.05, �� p< 0.005, ��� p< 0.005.
Supporting information
S1 Fig. Characterization of ASAP1 gene-trap mice. (A) Insertion of the gene-trap vector
into the ASAP1 gene locus was verified by genotyping PCR. Three primers were designed that
specifically bind to either genomic ASAP1 sequences (Asap1_for; Asap1_rev) or to a sequence
specific for the Gene-trap vector (Gene-trap_for). Asap1_rev primer binds to a portion of the
ASAP1 genomic sequence flanking the gene-trap insertion site, and therefore binds to both
the WT and GT genotypes. Asap1_for binds to a portion of the genomic sequence deleted in
GT animals. The Asap1_for and Asap1_rev primer pair specifically amplifies a 330 bp ampli-
con when a wild-type allele is present. The Gene-trap_for primer together with the Asap1_rev
primers amplifies a 680 bp amplicon only in the knock-out allele, when the gene-trap vector is
present. A representative result of a PCR in which examples for genotyping of Asap1+/+,
Asap1+/GT and Asap1GT/GT mice are shown is depicted (lower panel). Water instead of geno-
mic DNA served as a negative control. (B) 3’-terminal parts of ASAP1 are not expressed upon
gene-trap vector insertion. qPCR analysis using different primer pairs targeting exons 11–13,
exons 21–24 or exons 29–30 of the ASAP1 gene locus was performed with cDNA from
Asap1+/+ and Asap1GT/GT MEFs. (C) Table showing Mendelian distribution of FVB; Asap1
progeny. Asap1+/GT mice were intercrossed and progeny was genotyped at the age 10 days.
(TIF)
S2 Fig. ASAP1 is expressed in adult organs. (A-H) X-Gal staining of trachea (A), heart (B),
brain (C), bone (D), lung (E, F) and spleen (G, H). (A-D, F, H) Organs from an Asap1GT/GT
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adult mouse. (E, G) Organs from an Asap1+/+ adult mouse. (I) Western blot analysis of differ-
ent organs isolated from Asap1+/+ and Asap1GT/GT adult mice. Protein lysates were prepared
from heart, lung, liver, brain and testis and ASAP1 expression was detected using ASAP1 anti-
body. Vinculin served as loading control.
(TIF)
S3 Fig. ASAP1 does not affect retinal angiogenesis and lymphangiogenesis. (A) Representa-
tive pictures of stained retinas from Asap1+/+ and Asap1GT/GT neonates at P7 (B) Quantifica-
tion of the angiogenic area of stained Asap1+/+ and Asap1GT/GT retinas (n = 3, n = 4). (C)
Analysis of ASAP1 mRNA expression in Asap1+/+ lung, Asap1GT/GT tissue and Asap1+/+ tho-
racic duct using semi-quantitative PCR. RT-, RNA without added reverse trancriptase, and
water served as control. (D) No significant difference was observed in lymphatic vessel density
in the skin from Asap1+/+ and Asap1GT/GT mice (n = 6, n = 6, p = 0.5). (E) No significant differ-
ence was observed in lymphangiogenesis in thoracic duct ring assays using thoracic duct from
Asap1+/+ and Asap1GT/GT mice (n = 30, n = 54, p = 0.7).
(TIF)
S4 Fig. Focal adhesion formation and adhesion capacity is not impaired by loss of ASAP.
WT (A, C, E) and Asap1GT/GT MEFs (B, D, F) were plated on gelatin-coated cover slips and
were either treated for 1h or for 24 h with adipogenic differentiation cocktail, or left untreated
(control). Cells were stained using anti-vinculin (in green) and anti-phospho-FAK antibodies
(in red). Scale bars: 50μm. (G) Adhesion of WT and Asap1GT/GT MEFs to tissue culture plastic
coated with fibronectin, laminin and collagen I. Cells were allowed to adhere for 1h at 37˚C.
Adhered cells were stained with crystal violet. Bound dye was extracted using 10% acetic acid
and absorbance was measured at 595 nm. Data are presented as the mean +/- SE of triplicate
samples.
(TIF)
S1 Table. Primer sets used in qPCR.
(PDF)
S1 File. Supplementary methods.
(PDF)
S1 Data. Underlying numerical data. File of raw data underlying graphs in main figures.
(XLSX)
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